ITCI Intra Cellular Therapies Inc

Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders.

$32.98  -1.47 (-4.25%)
As of 03/03/2021 15:59:24 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Biotechnology
USA
USA
12/27/2013
80,917,013
664,061
$2,786,781,928
0.00%
SEC Edgar Online
10-Q
10-K
46116X101
US46116X1019
BHCB0P4

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-12.28
4.22
122.16
-34.56%
-995.07%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy